Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacterial Infections

Experimental Model of Human Body Louse Infection Using Green Fluorescent Protein-Expressing Bartonella quintana

Pierre-Edouard Fournier, Michael F. Minnick, Hubert Lepidi, Eric Salvo, Didier Raoult
Pierre-Edouard Fournier
Unité des rickettsies, CNRS:UPRESA 6020, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael F. Minnick
Division of Biological Sciences, University of Montana, Missoula, Montana 59812-1002
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hubert Lepidi
Unité des rickettsies, CNRS:UPRESA 6020, and
Laboratoire d'Histologie, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex 05, France, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Salvo
Unité des rickettsies, CNRS:UPRESA 6020, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Raoult
Unité des rickettsies, CNRS:UPRESA 6020, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.3.1876-1879.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A laboratory colony of human body lice was experimentally infected by feeding on rabbits made artificially bacteremic with a green fluorescent protein-expressing Bartonella quintana. B. quintana was detected in the gut and feces until death but not in the eggs. The life span of the lice was not modified. The rabbit model should provide valuable clues to the role of lice in the transmission of B. quintana.

Bartonella quintana is a fastidious gram-negative bacterium that is regarded as a reemerging human pathogen (1) and is responsible for various human diseases (12). Although trench fever, the first clinical manifestation of B. quintana infection to be recognized (13), affected thousands of soldiers during World Wars I and II, medical interest in trench fever waned for almost 30 years because the disease was only rarely encountered. In the 1990s, B. quintana was identified as an agent of bacillary angiomatosis in AIDS patients (17), endocarditis (5, 16, 18), chronic bacteremia (3, 19), and chronic lymphadenopathy (15). These diseases are associated with homelessness or cramped, unhygienic circumstances, together with cold weather and the presence of body lice. The role of lice had been observed as early as 1920 (4). Various experiments have demonstrated that the disease could be induced in human volunteers (20) and Macacus rhesus monkeys (14) by injection ofB. quintana and that the bacterium multiplied in the gut lumen of naturally (21) or intrarectally (8) infected lice without interfering with viability and was excreted in their feces (4, 8). However, despite growing interest in louse-transmitted diseases, there is no currently available experimental model to describe the relationship betweenB. quintana and the louse.

GFP-expressing B. quintana. B. quintanastrain Oklahoma (ATCC 49793) was obtained from the American Type Culture Collection (Rockville, Md.) and cultivated as previously described (10). Plasmid pJMBGFP, containing the B. bacilliformis flagellin promoter and a Rep origin of replication obtained from pBBR1-MCS2 (9) (Table1), was provided by James M. Battisti (Division of Biological Sciences, University Montana, Missoula, Mont.). It was extracted and purified from Escherichia coli using a Midi Prep kit (Qiagen, Inc., Chatsworth, Calif.) and then adjusted to 0.5 μg/ml. Transformation procedures were as previously described (6). The transformed bacteria were cultivated on 5% sheep blood agar containing 25 μg of kanamycin sulfate per ml and were further verified as B. quintana by PCR amplification of the 16S-23S rDNA intergenic spacer (its) followed by sequencing (6). The presence of plasmid DNA was checked as previously described (6).

View this table:
  • View inline
  • View popup
Table 1.

Strains and plasmids used in this study

Optimal transformation efficiencies were obtained at 6 ms for a field strength of 12.5 kV/cm and a plasmid DNA amount of 60 to 80 ng but were low, ranging from 3 × 10−5 to 7 × 10−5. Colonies of green fluorescent protein (GFP)-expressing B. quintana began to appear at aproximately 12 to 16 days following electroporation, which represents a growth lag time of approximately 8 to 12 days compared with the growth of untransformed bacteria on plate-to-plate passage. The colonies were typically smaller than those formed by untransformedB. quintana at the same stage of growth. When the colonies were subcultured on selective media, GFP expression was conserved after 15 passages, suggesting that plasmid maintenance was stable in the presence of antibiotic, but was lost after 5 passages in the absence of antibiotic. No growth was obtained on selective media with wild-type B. quintana prepared under the same conditions or B. quintana electroporated without DNA. Sequencing of PCR-products amplified from the its revealed 100% identity to known sequences of B. quintana, confirming that the transformants were B. quintana.

Experimental body louse infection.Body lice (Pediculus humanus corporis, strain Orlando) were kindly provided by D. Richard-Lenoble (Laboratoire de Parasitologie, Faculté de Médecine, Tours, France). A colony of lice was established and nourished daily on the shaved abdomen of specific-pathogen-free (SPF) New Zealand White rabbits (Fig. 1a). The lice were shown to be free from B. quintana by periodicits PCR amplification of samples from their gut and feces. One SPF rabbit, designated R1, was first injected intravenously with 2.5 ml of a solution of 10 mg of kanamycin (Sigma, St. Louis, Mo.) per ml, and 15 min later was injected with 20 ml of a suspension of 106 CFU of pJMBGFP-expressing B. quintana per ml in saline, before 800 15-day-old lice, half of which were female, were allowed to feed on its abdomen. The lice were then kept at 30°C and 70% humidity. The day of infection was referred to as day 1. On the following days, lice were allowed to feed daily on a second SPF rabbit designated R2. Before the lice were allowed to feed each day, R2 was injected intravenously each day with 2.5 ml of 10 mg of kanamycin sulfate (Sigma) per ml. To detect B. quintana, itsamplification by PCR and culture on kanamycin-containing agar for up to 60 days at 37°C under a 5% CO2 atmosphere were performed on blood drawn from the infected rabbit after the lice had fed then every day for 5 days, and then once a week for 2 months. Similar tests were performed on 15 lice harvested after feeding on the infected rabbit, 15 lice harvested daily for 1 week and twice a week after that until no lice from the first generation remained, and, when present, eggs, larvae, and feces. Blood samples drawn from the infected rabbit (R1) were positive for B. quintana by culture and PCR on days 1 and 2, with 2 × 104/ml and 7 × 102 CFU/ml, respectively, but were negative on day 3 and at all later times. On follow-up, the rabbit did not present with any abnormal symptoms but developed an anti-B. quintanaimmunoglobulin G response by day 15, with a titer of 1:400 as determined by indirect immunofluorescence. Blood drawn from rabbit R2 was negative by both culture and PCR, and they did not seroconvert. GFP-expressing B. quintana was grown and PCR amplified from all groups of lice. Between 7 and 20 CFU of Bartonella(mean ± standard deviation = 16.3 ± 2.9) was obtained from each louse (Fig. 1b). The number of CFU did not decrease over time. B. quintana was also grown and PCR amplified from fecal samples harvested throughout the experiment. Qualitative but not quantitative analysis of the colonies grown from infected feces was performed. Only fluorescent colonies grew. The GFP marker was therefore very useful for directly identifying B. quintana colonies (Fig. 1B). None of the uninfected control lice were positive by culture or PCR analysis. The average daily number of eggs from the infected group was 682.8 ± 335.1 and was not significantly different from the 705.2 ± 357.9 observed in the control group (P = 0.51) . No growth or PCR amplification of B. quintanawas obtained from the 300 eggs and 100 larvae tested. Unfortunately, we observed that body lice were autofluorescent, and therefore detection of GFP-expressing Bartonella was not possible (Fig. 1c).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Experimental model of body louse infection by GFP-expressing B. quintana. (a) Pediculus humanus humanus feeding on a rabbit; (b) fluorescent colony isolated on selective agar from an infected louse 10 days after the initial infection; (c) autofluorescence of body lice; (d) immunohistological detection of B. quintana. Note the numerous erythrocytes and the clusters of bartonellae in the intestine lumen (red clumps) and against the intestine wall (blue). Streptavidin-biotin-peroxidase method, polyclonal rabbit anti-B. quintana used at a dilution of 1:400, hemalun counterstain. Magnification, ×660.

For histological examination, five lice collected on each of days 0, 3, 5, 7, and then once a week were fixed in 10% formalin overnight, paraffin embedded, and cut to 5-μm thickness. Hematoxylin-eosin stain was used to visualize the gut system, and Warthin-Starry stain was used to detect bartonellae. Immunochemistry using anti-B. quintana polyclonal antibodies (11) was performed on 5-μm-thick formalin-fixed and paraffin-embedded gut sections. For each section, a negative control was prepared using gut sections from uninfected lice. The gut system was easy to recognize by its thin wall and large lumen. Bartonella were identified as dense clusters of bacteria in the intestinal lumen. Masses of bacteria occupied an extracellular location (Fig. 1d).

To determine whether B. quintana would influence louse mortality, 200 infected lice, half of which were female, were fed daily on rabbit R2 and were compared with 200 control lice, half of which were female, that fed only on an SPF rabbit (R3). The number of dead lice in both groups was compared using a Kaplan-Meier life table (GB-STAT version 6.5; Dynamic Systems Inc., Silver Springs, Md.), and the equality of survival between the two populations was estimated using the generalized Wilcoxon test. No significant difference in the mortality rate was observed between infected and control lice (P = 0.49) (Fig. 2).

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Comparison of the survival rate over time of 200 lice infected with B. quintana and 200 control lice. Day 0, day of infection.

In conclusion, we report the first experimental animal model of body louse infection by using a laboratory colony of lice feeding on a rabbit with a GFP-expressing B. quintana bacteremia. The lice maintained an asymptomatic extracellular infection inside their gut during their entire life but did not transmit B. quintana to the next generation, supporting the role of body lice as vectors, but not reservoirs, for B. quintana. This rabbit model of human body louse infection may be valuable for other louse-transmitted pathogens.

ACKNOWLEDGMENTS

We thank James M. Battisti, Michael Kovacs, and Raphael Valdivia for kindly providing plasmids.

Notes

Editor: V. J. DiRita

FOOTNOTES

    • Received 7 August 2000.
    • Accepted 18 October 2000.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anderson B. E.,
    2. Neuman M. A.
    Bartonella spp. as emerging human pathogens.Clin. Microbiol. Rev.101997203219
    OpenUrlAbstract/FREE Full Text
  2. 2.
    1. Battisti J. M.,
    2. Minnick M. F.
    Development of a system for genetic manipulation of Bartonella bacilliformis.Appl. Environ. Microbiol.65199934413448
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Brouqui P.,
    2. La Scola B.,
    3. Roux V.,
    4. Raoult D.
    Chronic Bartonella quintana bacteremia in homeless patients.N. Engl. J. Med.3401999184189
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Byam W.,
    2. Lloyd L. L.
    Trench fever: Its epidemiology and endemiology.R. Soc. Med. Proc.131920127
    OpenUrl
  5. 5.↵
    1. Drancourt M.,
    2. Mainardi J. L.,
    3. Brouqui P.,
    4. Vandenesch F.,
    5. Carta A.,
    6. Lehnert F.,
    7. Etienne J.,
    8. Goldstein F.,
    9. Acar J.,
    10. Raoult D.
    Bartonella (Rochalimaea) quintana endocarditis in three homeless men.N. Engl. J. Med.3321995419423
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Fournier P. E.,
    2. Minnick M.,
    3. Raoult D.
    Transformation of Bartonella quintana to green fluorescent protein expression by electroporation Rickettsiae and rickettsial diseases at the turn of the third millenium. Raoult D., Brouqui P. 1999 38 42 Elsevier Marseilles, France
  7. 7.
    1. Hanahan D.
    Studies on transformation of Escherichia coli with plasmids.J. Mol. Biol.1661983557580
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Ito S.,
    2. Vinson J. W.
    Fine structure of rickettsia quintana cultivated in vitro and in the louse.J. Bacteriol.891965481495
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kovach M. E.,
    2. Elzer P. H.,
    3. Hill D. S.,
    4. Robertson S. T.,
    5. Farris M. A.,
    6. Roop R. M. I.,
    7. Peterson K. M.
    Four different derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes.Gene1661995175176
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. La Scola B.,
    2. Raoult D.
    Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998).J. Clin. Microbiol.37199918991905
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Liang Z.,
    2. Raoult D.
    Species-specific monoclonal antibodies for rapid identification of Bartonella quintana.Clin. Diagn. Lab. Immunol.720004044
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Maurin M.,
    2. Raoult D.
    Bartonella (Rochalimaea) quintana infections.Clin. Microbiol. Rev.91996273292
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. McNee J. W.,
    2. Renshaw A.,
    3. Brunt E. H.
    “Trench fever”: a relapsing fever occurring with the British forces in France.Br. Med. J.121916225234
    OpenUrlCrossRef
  14. 14.↵
    1. Mooser H.,
    2. Weyer F.
    Experimental infection of Macacus rhesus with Rickettsia quintana (trench fever).Proc. Soc. Exp. Biol. Med.831953699701
    OpenUrl
  15. 15.↵
    1. Raoult D.,
    2. Drancourt M.,
    3. Carta A.,
    4. Gastaut J. A.
    Bartonella (Rochalimaea) quintana isolation in patient with chronic adenopathy, lymphopenia, and a cat.Lancet3431994977
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Raoult D.,
    2. Fournier P. E.,
    3. Drancourt M.,
    4. Marrie T. J.,
    5. Etienne J.,
    6. Cosserat J.,
    7. Cacoub P.,
    8. Poinsignon Y.,
    9. Leclercq P.,
    10. Sefton AM.
    Diagnosis of 22 new cases of Bartonella endocarditis.Ann. Intern. Med.1251996646652
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Relman D. A.,
    2. Loutit J. S.,
    3. Schmidt T. M.,
    4. Falkow S.,
    5. Tompkins L. S.
    The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens.N. Engl. J. Med.323199015731580
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Spach D. H.,
    2. Kanter A. S.,
    3. Daniels N. A.,
    4. Nowowiejski D. J.,
    5. Larson A. M.,
    6. Schmidt R. A.,
    7. Swaminathan B.,
    8. Brenner D. J.
    Bartonella (Rochalimaea) species as a cause of apparent “culture-negative” endocarditis.Clin. Infect. Dis.20199510441047
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Spach D. H.,
    2. Kanter A. S.,
    3. Dougherty M. J.,
    4. Larson A. M.,
    5. Coyle M. B.,
    6. Brenner D. J.,
    7. Swaminathan B.,
    8. Matar G. M.,
    9. Welch D. F.,
    10. Root R. K.,
    11. Stamm W. E.
    Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism.N. Engl. J. Med.3321995424428
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Vinson J. W.,
    2. Varela G.,
    3. Molina-Pasquel C.
    Trench fever. III. Induction of clinical disease in volunteers inoculated with Rickettsia quintana propagated on blood agar.Am. J. Trop. Med. Hyg.181969713722
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Weigl R.
    Further studies on rickettsia rochalimae.J. Trop. Med. Hyg.2719241415
    OpenUrl
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Experimental Model of Human Body Louse Infection Using Green Fluorescent Protein-Expressing Bartonella quintana
Pierre-Edouard Fournier, Michael F. Minnick, Hubert Lepidi, Eric Salvo, Didier Raoult
Infection and Immunity Mar 2001, 69 (3) 1876-1879; DOI: 10.1128/IAI.69.3.1876-1879.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Experimental Model of Human Body Louse Infection Using Green Fluorescent Protein-Expressing Bartonella quintana
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Experimental Model of Human Body Louse Infection Using Green Fluorescent Protein-Expressing Bartonella quintana
Pierre-Edouard Fournier, Michael F. Minnick, Hubert Lepidi, Eric Salvo, Didier Raoult
Infection and Immunity Mar 2001, 69 (3) 1876-1879; DOI: 10.1128/IAI.69.3.1876-1879.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bartonella quintana
Luminescent Proteins
Pediculus

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522